95 related articles for article (PubMed ID: 1068197)
1. Laboratory characteristics of an attenuated influenza type A (H3N2) virus ('Alice' strain).
Lobmann M; Delem A; Peetermans J; Huygelen C
J Hyg (Lond); 1976 Oct; 77(2):181-8. PubMed ID: 1068197
[TBL] [Abstract][Full Text] [Related]
2. Production of an attenuated influenza A (H3N2) strain "KO-1" by recombination with A/Okuda/57 (H2N2) followed by selection of inhibitor-resistant virus.
Yamada A; Okuno Y; Takahashi M; Nakajima K
Biken J; 1980 Mar; 23(1):25-32. PubMed ID: 7437002
[TBL] [Abstract][Full Text] [Related]
3. Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan.
Iwahashi J; Tsuji K; Ishibashi T; Kajiwara J; Imamura Y; Mori R; Hara K; Kashiwagi T; Ohtsu Y; Hamada N; Maeda H; Toyoda M; Toyoda T
J Clin Microbiol; 2001 Apr; 39(4):1652-3. PubMed ID: 11283109
[TBL] [Abstract][Full Text] [Related]
4. Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates.
Pemberton RM; Jennings R; Potter CW; Oxford JS
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():135-40. PubMed ID: 3793655
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.
Saito R; Li D; Suzuki Y; Sato I; Masaki H; Nishimura H; Kawashima T; Shirahige Y; Shimomura C; Asoh N; Degawa S; Ishikawa H; Sato M; Shobugawa Y; Suzuki H
J Med Virol; 2007 Oct; 79(10):1569-76. PubMed ID: 17705168
[TBL] [Abstract][Full Text] [Related]
6. Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada.
Higgins RR; Eshaghi A; Burton L; Mazzulli T; Drews SJ
J Clin Virol; 2009 Jan; 44(1):91-3. PubMed ID: 19019729
[TBL] [Abstract][Full Text] [Related]
7. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
Gohil DJ; Kothari ST; Shinde PS; Chintakrindi AS; Meharunkar R; Warke RV; Kanyalkar MA; Chowdhary AS; Deshmukh RA
Infect Genet Evol; 2015 Jan; 29():75-81. PubMed ID: 25461259
[TBL] [Abstract][Full Text] [Related]
8. Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006.
Saito R; Li D; Suzuki H
N Engl J Med; 2007 Jan; 356(3):312-3. PubMed ID: 17229966
[No Abstract] [Full Text] [Related]
9. Discovery of highly potent agents against influenza A virus.
Zhao X; Li C; Zeng S; Hu W
Eur J Med Chem; 2011 Jan; 46(1):52-7. PubMed ID: 21094565
[TBL] [Abstract][Full Text] [Related]
10. Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
Schmidtke M; Bauer K; Ludwig N; Wutzler P
Int J Antimicrob Agents; 2008 Aug; 32(2):192-5. PubMed ID: 18571381
[No Abstract] [Full Text] [Related]
11. High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005-2010.
Cho HG; Choi JH; Kim WH; Hong HK; Yoon MH; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Jan; 158(1):241-5. PubMed ID: 23011311
[TBL] [Abstract][Full Text] [Related]
12. Genomic events contributing to the high prevalence of amantadine-resistant influenza A/H3N2.
Zaraket H; Saito R; Suzuki Y; Suzuki Y; Caperig-Dapat I; Dapat C; Shabana II; Baranovich T; Suzuki H
Antivir Ther; 2010; 15(3):307-19. PubMed ID: 20516551
[TBL] [Abstract][Full Text] [Related]
13. Emergence of amantadine-resistant H3N2 avian influenza A virus in South Korea.
Lee J; Song YJ; Park JH; Lee JH; Baek YH; Song MS; Oh TK; Han HS; Pascua PN; Choi YK
J Clin Microbiol; 2008 Nov; 46(11):3788-90. PubMed ID: 18845822
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to amantadine of epidemic strain of H3 subtype influenza virus: a primary study].
Xu H; Qian Y; Xu H; Zhang JH; Zhu RN; Wang F
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):996-8. PubMed ID: 16759544
[TBL] [Abstract][Full Text] [Related]
15. Emergence and phylogenetic analysis of amantadine-resistant influenza a subtype H3N2 viruses in Dublin, Ireland, over Six Seasons from 2003/2004 to 2008/2009.
Salter A; Ni Laoi B; Crowley B
Intervirology; 2011; 54(6):305-15. PubMed ID: 21228542
[TBL] [Abstract][Full Text] [Related]
16. Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007.
Zaraket H; Saito R; Sato I; Suzuki Y; Li D; Dapat C; Caperig-Dapat I; Oguma T; Sasaki A; Suzuki H
Arch Virol; 2009; 154(2):285-95. PubMed ID: 19153639
[TBL] [Abstract][Full Text] [Related]
17. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.
Herlocher ML; Truscon R; Elias S; Yen HL; Roberts NA; Ohmit SE; Monto AS
J Infect Dis; 2004 Nov; 190(9):1627-30. PubMed ID: 15478068
[TBL] [Abstract][Full Text] [Related]
18. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001.
Schmidtke M; Zell R; Bauer K; Krumbholz A; Schrader C; Suess J; Wutzler P
Intervirology; 2006; 49(5):286-93. PubMed ID: 16809934
[TBL] [Abstract][Full Text] [Related]
19. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
Bai GR; Chittaganpitch M; Kanai Y; Li YG; Auwanit W; Ikuta K; Sawanpanyalert P
Biochem Biophys Res Commun; 2009 Dec; 390(3):897-901. PubMed ID: 19850010
[TBL] [Abstract][Full Text] [Related]
20. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
